# Many-body localization in a quasiperiodic system

Article · Shankar Iyer, Vadim Oganesyan, Gil Refael, David A. Huse

- Archive id: arxiv:1212.4159
- Published: 2013-04-08
- Venue: Physical Review B
- DOI: https://doi.org/10.1103/physrevb.87.134202
- arXiv: https://arxiv.org/abs/1212.4159
- Citations: 421
- Source URL: https://doi.org/10.1103/physrevb.87.134202
- PDF: http://link.aps.org/pdf/10.1103/PhysRevB.87.134202
- Provenance: openalex+arxiv

## Abstract

Recent theoretical and numerical evidence suggests that localization can survive in disordered many-body systems with very high energy density, provided that interactions are sufficiently weak. Stronger interactions can destroy localization, leading to a so-called many-body localization transition. This dynamical phase transition is relevant to questions of thermalization in extended quantum systems far from the zero-temperature limit. It separates a many-body localized phase, in which localization prevents transport and thermalization, from a conducting ("ergodic") phase in which the usual assumptions of quantum statistical mechanics hold. Here, we present numerical evidence that many-body localization also occurs in models without disorder but rather a quasiperiodic potential. In one dimension, these systems already have a single-particle localization transition, and we show that this transition becomes a many-body localization transition upon the introduction of interactions. We also comment on possible relevance of our results to experimental studies of many-body dynamics of cold atoms and non-linear light in quasiperiodic potentials.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Quantum Many-Body Physics & Simulation](https://space-kitty.com/topics/many-body-quantum-simulation)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.